Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
12 NC counties are under alert, including Wake, Durham, Johnston, Orange, and Nash counties.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zynerba Pharma CS
(NQ:
ZYNE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 10, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zynerba Pharma CS
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Cannabis Stock Movers For August 3, 2023
August 03, 2023
Via
Benzinga
Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting
July 25, 2023
Annual Meeting to Reconvene on August 11, 2023 at 9:00 a.m. EDT
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
March 08, 2023
On Wednesday, 116 companies set new 52-week lows.
Via
Benzinga
Marijuana Stock Movers For August 2, 2023
August 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 19, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 18, 2023
July 18, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 14, 2023
July 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 13, 2023
Via
Benzinga
Marijuana Stock Movers For July 12, 2023
July 12, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 11, 2023
July 11, 2023
Via
Benzinga
Cannabis Stock Movers For July 10, 2023
July 10, 2023
Via
Benzinga
Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting
June 28, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Why Theriva Biologics Are Trading Higher By Over 76%; Here Are 20 Stocks Moving Premarket
June 28, 2023
Gainers Theriva Biologics, Inc. (NYSE: TOVX) shares surged 76.4% to $1.46 in pre-market trading after the company said Orphan Drug Designation was granted by the U.S. Food and Drug Administration for...
Via
Benzinga
Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
June 27, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 27, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on Tuesday morning!
Via
InvestorPlace
Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference
June 20, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Zynerba Pharmaceuticals Announces Partial Adjournment of Annual Meeting
June 13, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Zynerba Pharmaceuticals Announces Podium and Poster Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
May 23, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Zynerba Pharmaceuticals R&D Expenses For Q1 Reach $7.1M, Here Are The Details
May 15, 2023
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) released financial results for the first quarter ended March 31, 2023, revealing research and development expenses were $7.1 million for the first quarter...
Via
Benzinga
Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights
May 15, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
April 26, 2023
On Wednesday, 345 companies set new 52-week lows.
Via
Benzinga
Zynerba Pharmaceuticals Presents Data on Zygel™ at the 55th Gatlinburg Conference
April 12, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Zynerba Pharmaceuticals Announces Poster Presentations at the 55th Gatlinburg Conference
April 05, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Zynerba Pharmaceuticals R&D Expenses For FY22 Reach $21.1M, What About Net Loss?
March 28, 2023
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) released financial results for the fourth quarter and full year ended December 31, 2022, revealing research and development expenses were $21.1 million for...
Via
Benzinga
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
March 28, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Silicon Valley Bank Failure Is Just The Tip Of Financial Iceberg, Could Affect Unexpected Industries
March 14, 2023
Last week the US economy got clobbered by the biggest banking collapse since 2008 when the parent of Silicon Valley Bank, SVB Financial Group (NASDAQ: SIVB) failed to raise enough capital to continue.
Via
Benzinga
Zynerba Pharmaceuticals Confirms Not Holding Cash Deposits or Securities at Silicon Valley Bank
March 13, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
March 10, 2023
On Friday, 497 companies set new 52-week lows.
Via
Benzinga
Zynerba Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023
From
Zynerba Pharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
March 06, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.